Girndt M - Search Results

1

Molecular aspects of T- and B-cell function in uremia.

Girndt M, Sester M, Sester U, Kaul H, Köhler H. Girndt M, et al. Kidney Int Suppl. 2001 Feb;78:S206-11. doi: 10.1046/j.1523-1755.2001.59780206.x. Kidney Int Suppl. 2001. PMID: 11169012 Free article. Review.

2

Hepatitis B virus infection in hemodialysis patients.

Girndt M, Köhler H. Girndt M, et al. Semin Nephrol. 2002 Jul;22(4):340-50. Semin Nephrol. 2002. PMID: 12118399 Review.

3

Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events.

Girndt M, Kaul H, Sester U, Ulrich C, Sester M, Georg T, Köhler H. Girndt M, et al. Kidney Int. 2002 Sep;62(3):949-55. doi: 10.1046/j.1523-1755.2002.00504.x. Kidney Int. 2002. PMID: 12164877 Free article.

4

Uremia-associated immune defect: the IL-10-CRP axis.

Girndt M, Ulrich C, Kaul H, Sester U, Sester M, Köhler H. Girndt M, et al. Kidney Int Suppl. 2003 May;(84):S76-9. doi: 10.1046/j.1523-1755.63.s84.14.x. Kidney Int Suppl. 2003. PMID: 12694315 Free article. Review.

5

Transforming growth factor beta1 genotype polymorphisms determine AV fistula patency in hemodialysis patients.

Heine GH, Ulrich C, Sester U, Sester M, Köhler H, Girndt M. Heine GH, et al. Among authors: girndt m. Kidney Int. 2003 Sep;64(3):1101-7. doi: 10.1046/j.1523-1755.2003.00176.x. Kidney Int. 2003. PMID: 12911563 Free article.

6

Glucocorticoids inhibit activation-dependent expression of costimulatory molecule B7-1 in human monocytes.

Girndt M, Sester U, Kaul H, Hünger F, Köhler H. Girndt M, et al. Transplantation. 1998 Aug 15;66(3):370-5. doi: 10.1097/00007890-199808150-00015. Transplantation. 1998. PMID: 9721807

7

Production of proinflammatory and regulatory monokines in hemodialysis patients shown at a single-cell level.

Girndt M, Sester U, Kaul H, Köhler H. Girndt M, et al. J Am Soc Nephrol. 1998 Sep;9(9):1689-96. doi: 10.1681/ASN.V991689. J Am Soc Nephrol. 1998. PMID: 9727378 Clinical Trial.

8

Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction.

Girndt M, Lengler S, Kaul H, Sester U, Sester M, Köhler H. Girndt M, et al. Am J Kidney Dis. 2000 Jan;35(1):95-104. doi: 10.1016/S0272-6386(00)70307-6. Am J Kidney Dis. 2000. PMID: 10620550 Clinical Trial.

9

Initiation of hemodialysis treatment leads to improvement of T-cell activation in patients with end-stage renal disease.

Kaul H, Girndt M, Sester U, Sester M, Köhler H. Kaul H, et al. Among authors: girndt m. Am J Kidney Dis. 2000 Apr;35(4):611-6. doi: 10.1016/s0272-6386(00)70006-0. Am J Kidney Dis. 2000. PMID: 10739780 Clinical Trial.

10

T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients.

Sester U, Sester M, Hauk M, Kaul H, Köhler H, Girndt M. Sester U, et al. Among authors: girndt m. Nephrol Dial Transplant. 2000 Aug;15(8):1217-23. doi: 10.1093/ndt/15.8.1217. Nephrol Dial Transplant. 2000. PMID: 10910448

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters